Tandutinib
Tandutinib (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also inhibit c-Kit and PDGFR, 15-20 fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR, and KDR.
| Catalog Number | T1667 |
| Alternative Name(s) | MLN518 , CT53518 , NSC726292 |
| Research Area | Apoptosis|||Tyrosine Kinase/Adaptors|||Angiogenesis |
| Molecular Formula | C31H42N6O4 |
| CAS# | 387867-13-2 |
| Purity | 99.74% |
| SMILES | N1(CCN(CC1)c1ncnc2c1cc(c(c2)OCCCN1CCCCC1)OC)C(=O)Nc1ccc(cc1)OC(C)C |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Tandutinib |
| Additional Information | https://www.targetmol.com/datasheet/T1667 |